Waystar Holding Corp. (NASDAQ:WAY) Receives Average Rating of “Moderate Buy” from Analysts

Waystar Holding Corp. (NASDAQ:WAY) has been given a consensus recommendation of “Moderate Buy” by the twenty-four brokerages that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, eighteen have assigned a buy rating and three have issued a strong buy rating on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $35.2273.

Several equities analysts have recently weighed in on the stock. JPMorgan Chase & Co. decreased their price target on shares of Waystar from $40.00 to $38.00 and set an “overweight” rating for the company in a research note on Thursday, April 30th. Bank of America cut their price objective on shares of Waystar from $45.00 to $38.00 and set a “buy” rating on the stock in a research report on Friday, April 10th. Wall Street Zen cut shares of Waystar from a “buy” rating to a “hold” rating in a report on Sunday, May 24th. Weiss Ratings downgraded shares of Waystar from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, June 24th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $33.00 price target on shares of Waystar in a research note on Thursday, April 30th.

Hedge Funds Weigh In On Waystar

Several hedge funds have recently modified their holdings of WAY. Advent International L.P. bought a new position in shares of Waystar in the fourth quarter valued at $362,212,000. Alliancebernstein L.P. increased its holdings in Waystar by 3,883.4% during the second quarter. Alliancebernstein L.P. now owns 3,268,932 shares of the company’s stock worth $133,601,000 after buying an additional 3,186,869 shares during the last quarter. Alyeska Investment Group L.P. raised its position in Waystar by 4,717.4% during the third quarter. Alyeska Investment Group L.P. now owns 1,814,648 shares of the company’s stock worth $68,811,000 after acquiring an additional 1,776,979 shares in the last quarter. Bamco Inc. NY bought a new stake in Waystar during the fourth quarter worth $45,642,000. Finally, Norges Bank acquired a new stake in Waystar in the fourth quarter valued at $44,627,000.

Waystar Price Performance

WAY stock opened at $22.51 on Wednesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.76 and a quick ratio of 1.76. The stock has a market capitalization of $4.32 billion, a P/E ratio of 33.60, a P/E/G ratio of 0.89 and a beta of 0.08. Waystar has a fifty-two week low of $17.26 and a fifty-two week high of $41.47. The business has a 50-day moving average of $20.45 and a 200-day moving average of $23.51.

Waystar (NASDAQ:WAY) last announced its earnings results on Wednesday, April 29th. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.03. The business had revenue of $313.87 million for the quarter, compared to analyst estimates of $311.74 million. Waystar had a return on equity of 6.99% and a net margin of 10.90%.Waystar’s revenue for the quarter was up 22.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.32 EPS. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. On average, sell-side analysts anticipate that Waystar will post 1.46 earnings per share for the current fiscal year.

Waystar Company Profile

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.